Arpida (SIX: ARPN) is a biopharmaceutical company headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. It focuses on novel drugs that seek to overcome the growing problem of microbial resistance. Arpida’s leading product candidate is intravenous iclaprim, an antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
| Website | http://www.arpida.com |
| Revenue | $9.2 million |
| Employees | 30 (9 on RocketReach) |
| Founded | 1997 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+9 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Discovery, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Keywords | Antimicrobial Resistance, Antibiotic Resistance, Drug Resistance, Microbial Resistance, Pharmaceutical Research, Biopharmaceutical, Novel Drugs, Drug Development, Infection Treatment, Antibacterial Drugs, Anti-Infective, Pharmaceutical, Clinical Trials, Drug Discovery, Health, Therapeutics, Medicine, Biotechnology, Healthcare |
| Competitors | Johnson & Johnson, Novartis, AbbVie, Merck & Co., Inc., Sanofi, GSK, AstraZeneca, Boehringer Ingelheim, Pfizer, Lilly India +46 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Arpida employee's phone or email?
The Arpida annual revenue was $9.2 million in 2026.
9 people are employed at Arpida.
The NAICS codes for Arpida are [32541, 325, 3254, 32].
The SIC codes for Arpida are [28, 283, 2834].